Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Series A Convertible Preferred Stock
Accretion on Series A convertible preferred stock	$ 0
Ending balance (in shares) at Dec. 31, 2022	0
Ending balance at Dec. 31, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021		8,071,183
Beginning balance at Dec. 31, 2021	$ 55,191	$ 1	$ 198,612	$ (143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	58,337	58,337
Issuance of common stock upon exercise of stock options	$ 259		259
Issuance of common stock for restricted stock units vesting (in shares)		94,552
Issuance of common stock for employee stock purchase plan (in shares)		17,937
Issuance of common stock for employee stock purchase plan	359		359
Stock-based compensation	12,892		12,892
Net loss	(79,336)			(79,336)
Ending balance (in shares) at Dec. 31, 2022		8,242,009
Ending balance at Dec. 31, 2022	$ (10,635)	$ 1	212,122	(222,758)
Series A Convertible Preferred Stock
Issuance of Series A convertible preferred stock (in shares)	30,000
Issuance of Series A convertible preferred stock	$ 3,867
Preferred stock issuance costs	(253)
Accretion on Series A convertible preferred stock	$ 4,591
Conversion of preferred stock (in shares)	(1,372)
Conversion of preferred stock	$ (350)
Ending balance (in shares) at Dec. 31, 2023	28,628
Ending balance at Dec. 31, 2023	$ 7,855
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on Series A convertible preferred stock	(4,591)		(4,591)
Conversion of preferred stock (in shares)		200,000
Conversion of preferred stock	350		350
Issuance of SVB Warrants (Note 6)	$ 43		43
Issuance of common stock upon exercise of stock options (in shares)	18,054	18,054
Issuance of common stock upon exercise of stock options	$ 55		55
Issuance of common stock for restricted stock units vesting (in shares)		294,119
Issuance of common stock for employee stock purchase plan (in shares)		43,274
Issuance of common stock for employee stock purchase plan	215		215
Stock-based compensation	9,933		9,933
Net loss	(32,901)			(32,901)
Ending balance (in shares) at Dec. 31, 2023		8,797,456
Ending balance at Dec. 31, 2023	$ (37,531)	$ 1	$ 218,127	$ (255,659)